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and Ru Zhao1*Abstract
Background: Marjolin’s ulcer (MU) is a rare malignancy arising from various forms of scars. This potentially fatal
complication typically occurs after a certain latency period. This article attempts to reveal the importance of the
latency period in the prevention and early treatment of the malignancy.
Methods: A retrospective review of 17 MU patients who underwent surgical procedures between June of 2005 and
December 2011 was conducted. Etiology of injuries, latency period, repeated ulceration, and outcomes were
recorded. This observational report reveals characteristics of patients who develop MU.
Results: An incidence of 0.7% of MU was found amongst patients complaining of existing scars in our study; burns
and trauma were the most common etiology of MU. The mean latency period was 29 years (SD = 19) and the
mean post-ulceration period was 7 years (SD = 9). Statistical analysis revealed a negative correlation between the
age of patients at injury and the length of latency period (r = −0.8, P <0.01), as well as the lengths of pre-ulceration
and post-ulceration periods (r = −0.7, P <0.01).
Conclusions: Patients experience different lengths of pre- and post-ulceration periods during the latency period.
Younger patients tend to have a longer latency period. Skin breakdown on chronic scars and chronic unhealed
ulcers are two main sources of MU. MU may be preventable with a close surveillance of the ulcer during the
latency period.
Keywords: Marjolin’s ulcer, Squamous cell carcinomaBackground
Marjolin’s ulcer (MU) refers to a rare but highly aggres-
sive ulcerating squamous cell carcinoma (SCC) that is
most often presented in an area of chronic burn wounds
[1]. However, it is also associated with chronic inflam-
matory states, as in non-healing wounds, venous ulcers,
lupus vulgaris, vaccination scars, snake bite scars, pres-
sure sores, osteomyelitis zones, pilonidal abscess, and
radiotherapy areas [2-4]. Celsus first described the ma-
lignant transformation of the thermal burn scar from his
observations dating back to the 1st century A.D. [5]. In the
19th century, the French surgeon Jean-Nicholas Marjolin
demonstrated the cellular changes of ulcerated lesions in
scar tissue [6], but it was not until Robert Smith in 1850* Correspondence: zhaorupumc@126.com
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reproduction in any medium, provided the orthat a detailed description of the pathology was published
and named “Marjolin’s ulcer” [7,8].
Although it has been more than 160 years since the
eponym was first used, the disagreement on the use of the
term “Marjolin’s ulcer” synonymously with burn scar car-
cinoma still exists [9]. The classic definition of MU only ap-
plies to the squamous cell variant [1,10,11], whereas the
term “scar tissue carcinoma” is used for all malignancies
arising in scars (Figure 1) [12]. Although some authors hold
that MU may also refer to the latter in a broad sense
[13-16], the use of this term as a name for different clinical
entities may not be appropriate. As numerous skin carcin-
omas have been found, their onset, signs, clinical features,
progression, and treatments can be completely different.
During the course of MU, the latency period is defined
as the time between initial injury and the confirmation of
a pathologic diagnosis of malignancy [1]. In our study, we
divided the latency period into two parts: a “pre-ulcerationThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Comparison of the concepts of MU, burn scar carcinoma, and scar tissue carcinoma. The intersection between MU and burn scar
carcinoma represents the etiology and pathological outcome in common. SCC = squamous cell carcinoma; BCC = basal cell carcinoma.
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appearance of an ulcerated lesion, and “post-ulceration
period” referring to the period from ulceration to the
diagnosis of SCC by a positive biopsy (Figure 2). By ana-
lyzing data of 17 cases, we aimed to reveal the role of
the latency period in the prevention and early detection
and treatment of MU.
Methods
In the period from June of 2005 and December 2011,
2,984 patients with scars of different causes and no previous
history of cancer were seen in the plastic surgery division,
at Peking Union Medical College Hospital, China. All scars,
regardless of appearance, underwent biopsy/pathologicalFigure 2 Various paths to malignancy during the latency period. Ulcer formexamination leading to the diagnosis of 17 cases of MU.
The majority of patients that were diagnosed complained of
chronic, disfiguring, non-healing ulcers. Our therapeutic
regimes were planned according to available guidelines,
clinical evaluation, biopsy results, surgical expertise, and
radiologic findings in a multidisciplinary approach with
other departments from our hospital.
Ten male and seven female patients ranging from 34
to 87 years old were diagnosed with MU. Characteristics
and areas of ulcers were recorded. These patients were
followed-up for an average of 2.9 years (1 to 6 years) after
treatment. Their medical records were reviewed and
stratified retrospectively. Demographic and relevant clinical
information is presented in Table 1, including etiology,ation is a key step between initial injury and final malignant transformation.
Table 1 Demographic characteristics of all the 17 MU cases
Patient Age
(years)
Gender Etiology Latency period
(years)
Pre-ulceration
period (years)
Cause for ulceration Repeated
or not
Localization Lesion
appearance
Treatment Outcome
1 56 M Flame burn 27 0 Incomplete healing Yes Left leg Ulcerated ALT flap Tumor-free for 5 years
2 87 M Venous ulcer 30 0 Spontaneous Yes Right leg Ulcerated Skin grafting Tumor-free for 2 years
3 71 M Trauma 10 0 Incomplete healing Yes Right gluteal Ulcerated SGAP flap Death
4 70 F Oil burn 1 0 Incomplete healing Yes Face Ulcerated Local flap Tumor-free for 3 years
5 82 M Trauma 2 0 Incomplete healing Yes Right hand Ulcerated Skin grafting Tumor-free for 6 years
6 60 F Trauma 8 0 Incomplete healing Yes Gluteal Ulcerated Skin grafting Death
7 71 M Trauma 10 5 Spontaneous Yes Left hand Ulcerated Skin grafting Tumor-free for 2 years
8 59 F Infection 30 10 Spontaneous Yes Back Ulcerated Skin grafting Lost to follow-up
9 34 M Flame burn 32 13 Spontaneous Yes Scalp Ulcerated Skin grafting Death
10 42 M Steam burn 15 15 Spontaneous No Right leg Ulcerated Skin grafting Lost to follow-up
11 35 F Flame burn 35 29 Accidental abrasion Yes Scalp Ulcerated ALT flap Tumor-free for 1 year
12 57 F Trauma 42 41 Accidental abrasion No Left hand Ulcerated Skin grafting Recurrence 3 years later
13 48 F Infection 42 42 Scratching No Scalp Ulcerated Skin grafting Lost to follow-up
14 70 M Steam burn 45 45 Spontaneous No Right leg Ulcerated Skin grafting Tumor-free for 4 years
15 78 M Flame burn 45 45 No No Chest Exophytic Skin grafting Death
16 68 M Infection 58 58 Spontaneous No Gluteal Ulcerated SGAP flap Recurrence 1 year later
17 62 F Flame burn 61 60 Spontaneous No Scalp Ulcerated Skin grafting Tumor-free for 2 years
ALT flap = anterolateral thigh flap; SGAP flap = superior gluteal artery perforator flap.
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Figure 4 Relationship between the pre- and post-ulceration periods.
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and outcome.
All statistical algorithms were developed using the R
Project for statistical computing. Two-tailed Spearman
correlation was used, and P <0.05 was considered statisti-
cally significant.
The retrospective study was approved by the Institu-
tional Review Board of Peking Union Medical College
Hospital. Written informed consent was obtained from
each patient involved in this study.
Results
Patient history
Marjolin’s ulcer was diagnosed in patients with a mean
age of 62 years (34–87, SD = 15). In 82% of cases, more
than 10 years elapsed during the latency period, with an
average time of 29 years (SD = 19). However, an acute
form of presentation was seen in one patient (6%) diagnosed
1 year after the initial injury. The mean pre-ulceration
period was 21 years (SD = 22). The mean post-ulceration
period was 8 years (SD = 10).
Statistical analysis revealed a negative correlation (r =−0.8)
between the age of patients at which the initial injury
occurred and the length of the latency period (P <0.01)
(Figure 3). Similarly, a negative correlation (r = −0.7)
was found between the pre- and post-ulceration periods
(P <0.01) (Figure 4).
The main etiology was post-burn scars, which resulted
from flame (29%), steam (12%), and oil (6%) injuries. The
other diverse sources were trauma (29%), skin infections
(18%), and venous ulcers (6%). The most affected sites were
the scalp (24%), lower limbs (24%), upper limbs (18%),
and gluteal region (18%). Infection was reported in seven
patients (41%) and Staphylococcus aureus was isolated
in cultures.Figure 3 Relationship between the age of patients at initial
injury and the length of the latency period.Treatment
Surgical treatment was given to all patients. Wide exci-
sion with 3 cm of free margins to the border/base of
the ulcer was performed in every case. Reconstruction
was performed with split-thickness skin grafts (71%) or
musculocutaneous/cutaneous flaps (29%) depending on the
wound condition after excision (Figures 5, 6, and 7).
Excision of the external lamina was carried out for one
patient with skull invasion. Radiotherapy was applied
for advanced cases with ulcers of a diameter >10 cm, as
suggested by the oncology-radiotherapy department.
Regional lymph nodes were all carefully assessed by
palpation and superficial inguinal lymph node dissec-
tion was performed in one clinically suspicious case.
The pathological result was negative.
Follow-up/recurrence
During follow-up, three patients were lost to follow-up
and eight cases remained tumor-free. Four cases died
within one year after operation due to recurrence and
metastasis. Local recurrence was found in two cases;
one had MU on the left hand, and experienced another
ulceration of SCC on the left foot. The other presented a
new ulcerated mass, 4 cm away from the previous grafted
region. Both patients were re-admitted and treated with
wide re-excision and skin grafting.
Discussion
MU is a rare and aggressive cutaneous malignant trans-
formation with an incidence of 0.1% to 2.5% after a
long-term inflammatory or traumatic insult to the skin
[16,17]. The main etiology tends to be post-burn scars
and traumatic wounds [1]. Even though several theories
have been postulated to elucidate the mechanisms
generating this process, none can fully explain it [18].
Figure 5 Anterolateral thigh (ALT) flap reconstruction. (A) A 56-year-old male MU patient burned his left leg at the age of 29. (B) Preoperative
design of a reverse-flow ALT flap. (C) Reverse-flow ALT flap measured 20 cm× 10 cm, was elevated during operation. (D) Area of ulceration widely
excised and reconstructed with ALT flap three years postoperatively.
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of chronic irritation. Repeated ulceration to the scar
and subsequent initiation of re-epithelialization provides a
prolonged stimulus for cellular proliferation and may
increase the rate of spontaneous mutations [17,19,20].
An association between latency period and malignant
transformation was first suggested by Lawrence [21].
Along our practice, we realized that a typical latency
period of MU could be divided into two parts: pre- and
post-ulceration periods, both of which have been con-
sidered to correlate in some way during the course of
MU. Patient observations have also supported that the
length of the pre- and post-ulceration periods may vary
from one case to another.Figure 6 Superior gluteal artery perforator (SGAP) flap reconstruction
(B) Preoperative design of bilateral inferior gluteal artery perforator flaps. (CAfter a certain period of existence of a chronic scar, early
stages of MU usually present with symptoms of burning
and itching, followed by blisters and prurigo. During this
period, which we called the “pre-ulceration period”, the
surface of the scars remains intact. The duration of the
pre-ulceration period, or “the age of the scar”, may be
important for the prognosis of MU [22].
A new ulcer forms whenever the integrity of skin is
compromised by spontaneous rupture, scratching, or lack
of self-care. After ulceration, some patients will experience
repeated cycles of healing followed by rupturing of skin,
which is called repeated ulceration period [7]. At this stage,
ulcers protrude and deepen, accompanied with severe pain,
purulent discharge, foul odor, and bleeding. Malignant. (A) A 68-year-old male gluteal MU patient injured at the age of 58.
) Area of ulceration widely excised and covered with good results.
Figure 7 Anterolateral thigh (ALT) flap reconstruction. (A) A 35-year-old female MU patient had her scalp burned at the age of 6. (B) Anterior
and lateral views of the patient, one year after wide excision and reconstruction with ALT flap.
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the duration of ulceration. This means that the longer
the ulcer duration, the higher the risk of dysplasia [23].
Moreover, young patients tend to have a course of cyc-
ling between skin breakdown and repair before devel-
oping malignancy [21].
In our study, six patients (35%) reported that a small
portion of their initial injury never completely healed,
which means they experienced repeated ulceration
shortly after the initial injury. Therefore, the length of
the post-ulceration period was almost as long as that
of the latency period. While SCC can arise from these
kinds of unhealed chronic ulcers, it is not an uncommon
source for MU [9,24].
We found that the shorter the pre-ulceration period, the
longer the post-ulceration period will be, and vice versa.
Moreover, a chronic scar has a higher likelihood of devel-
oping carcinoma at the first ulceration. Prolonged healing
of the primary injury, that is, a prolonged post-ulceration
period is also a major potential risk factor for the develop-
ment of MU. Since biopsy remains the gold standard for
the diagnosis of MU [25,26], it should be applied for sus-
picious lesions that have not healed in 3 months.
A customized treatment regime should be designed after
carefully considering the clinical evaluation, pathologic, and
imaging results [27]. MU is more aggressive than primary
skin tumors, therefore nodal assessment and wide surgical
excision are recommended [28]. As recurrence of MU
is higher than normal SCC (11–37%), 2–4 cm of free
margins should be resected [2,3,7,29]. Frozen biopsy
during the operation is helpful, for MU always occurs
in varying depth [22,30]. Lifelong follow-ups should be
conducted according to our experience.
Moreover, since the majority of MUs occur in long-
duration unstable scars of ungrafted full-thickness burns
[31], the joint regions, especially flexion creases, are more
commonly involved due to predisposition to activity-related
repeated ulceration [1,7,32]. Early surgical management
could also achieve a possible prevention strategy.Conclusions
MU is a rare but highly aggressive ulcerating SCC.
The formation of an ulcer in the latency period plays
an important role in the course of MU. Based on the
different length of the pre- and post-ulceration pe-
riods during the latency period, skin breakdown on
chronic scars and chronic unhealed ulcers are two
main sources of MU. This potentially fatal complication
may be preventable and treatable by surgical management
of initial injuries and early diagnosis and treatment of
unhealed ulcers. Patients should be followed-up for the
rest of their life, as MU is more aggressive than initial
skin carcinomas.
Abbreviations
ALT flap: Anterolateral thigh flap; BCC: Basal cell carcinoma; SGAP
flap: Superior gluteal artery perforator flap; MU: Marjolin’s ulcer;
SCC: Squamous cell carcinoma.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NY: Conception and design, collection and assembly of data, data analysis
and interpretation, manuscript writing. XL: Conception and design,
manuscript writing. JRL-H: Data analysis and interpretation, manuscript
writing. KZH: Data analysis and interpretation, manuscript writing. MB:
Design, manuscript writing. YW: Collection of data. XW: Conception and
design, data analysis and interpretation, manuscript writing. RZ: Conception
and design, financial support, data analysis and interpretation, manuscript
writing, final approval of manuscript. All authors read and approved the
final manuscript.
Acknowledgments
Nanze Yu, M.D. is a recipient of a scholarship from the China Scholarship
Council.
Author details
1Division of Plastic Surgery, Peking Union Medical College Hospital, Peking
Union Medical College and Chinese Academy of Medical Science, No.1
Shuaifuyuan, Dongcheng District, Beijing 100730, China. 2Division of Plastic
Surgery, Brigham and Women’s Hospital and Harvard Medical School, 75
Francis Street, Boston, MA 02115, USA.
Received: 18 April 2013 Accepted: 3 December 2013
Published: 17 December 2013
Yu et al. World Journal of Surgical Oncology 2013, 11:313 Page 7 of 7
http://www.wjso.com/content/11/1/313Reference
1. Kerr-Valentic MA, Samimi K, Rohlen BH, Agarwal JP, Rockwell WB: Marjolin’s
ulcer: modern analysis of an ancient problem. Plast Reconstr Surg 2009,
123:184–191.
2. Bozkurt M, Kapi E, Kuvat SV, Ozekinci S: Current concepts in the
management of Marjolin’s ulcers: outcomes from a standardized
treatment protocol in 16 cases. J Burn Care Res 2010, 31:776–780.
3. Kadir AR: Burn scar neoplasm. Ann Burns Fire Disasters 2007, 20:185–188.
4. Copcu E, Aktas A, Sisman N, Oztan Y: Thirty-one cases of Marjolin’s ulcer.
Clin Exp Derm 2003, 28:138–141.
5. Tio J, Clarkson JHW, Mirsa A, Srivastava S: Malignant change after 18
months in a lower limb ulcer. Br J Plast Surg 2003, 56:825–828.
6. Marjolin JN: Ulcere. In Dictionnaire de Medicine. Vol. 21. Paris: Becher;
1828:31–50.
7. Huang CY, Feng CH, Hsiao YC, Chuang SS, Yang JY: Burn scar carcinoma.
J Dermatolog Treat 2010, 21:350–356.
8. Smith RW: Observations upon the warty ulcer of Marjolin. Dublin Quart J
Med Sci 1850, 9:257–275.
9. Kowal-Vern A, Criswell BK: Burn scar neoplasms: a literature review and
statistical analysis. Burns 2005, 31(4):403–413.
10. MacNalty SAS: British Medical Dictionary. London: Butterworth; 1961:876.
11. Cobey FC, Engrav LH, Klein MB, Isom CN, Byrd DR: Brief report: sentinel
lymph node dissection and burn scar carcinoma sentinel node and burn
scar carcinoma. Burns 2008, 34(2):271–274.
12. Arons MS, Lynch JB, Lewis SR, Blocker TG Jr: Scar tissue carcinoma. I.
A clinical study with special reference to burn scar carcinoma. Ann Surg
1965, 161:170–188.
13. Phillips TJ, Salman SM: Burn scar carcinoma. Dermatol Surg 1998, 22:561–565.
14. Turegun M, Nisanci M, Guler M: Burn scar carcinoma with longer lag
period arising in previously grafted area. Burns 1997, 23:496–497.
15. Baldursson BT, Hedblad MA, Beitner H, Lindelöf B: Squamous cell
carcinoma complicating chronic venous leg ulceration: a study of the
histopathology, course and survival in 25 patients. Br J Dermatol 1999,
140:1148–1152.
16. Dupree MT, Boyer JD, Cobb MW: SC arising in a burn scar. Cutis 1998,
6:49–51.
17. Gül U, Kiliç A: Squamous cell carcinoma developing on burn scar.
Ann Plast Surg 2006, 56:406–408.
18. Nthumba PM: Marjolin’s ulcers: theories, prognostic factors and their
peculiarities in spina bifida patients. World J Surg Oncol 2010, 8:108.
19. Fairbairn Hill BB, Sloan DA, Lee EY, McGrath PC, Kenady DE: Marjolin’s ulcer
of the foot caused by nonburn trauma. South Med J 1996, 89(7):707–710.
20. Fairbairn NG, Hamilton SA: Management of Marjolin’s ulcer in a chronic
pressure sore secondary to paraplegia: a radical surgical solution.
Int Wound J 2011, 8(5):533–536.
21. Lawrence EA: Carcinoma arising in the scars of thermal burns.
Surg Gynecol Obstet 1952, 95:579–588.
22. Mosborg DA, Crane RT, Tami TA, Parker GS: Burn scar carcinoma of the
head and neck. Arch Otolaryngol Head Neck Surg 1988, 114:1038–1040.
23. Smith J, Mello LF, Nogueira Neto NC, Meohas W, Pinto LW, Campos VA,
Barcellos MG, Fiod NJ, Rezende JF, Cabral CE: Malignancy in chronic ulcers
and scars of the leg (Marjolin’s ulcer): a study of 21 patients. Skeletal
Radiol 2001, 30:331–337.
24. Ozek C, Celik N, Bilkay U, Akalin T, Erdem O, Cagdas A: Marjolin’s ulcer of
the scalp: report of 5 cases and review of the literature. J Burn Care
Rehabil 2001, 22(1):65–69.
25. Enoch S, Miller DR, Price PE, Harding KG: Early diagnosis is vital in the
management of squamous cell carcinomas associated with chronic non
healing ulcers: a case series and review of the literature. Int Wound J
2004, 1:165–175.
26. Bauer T, David T, Rimareix F, Lortat-Jacob A: Marjolin’s ulcer in chronic
osteomyelitis: seven cases and a review of the literature. Rev Chir Orthop
Reparatrice Appar Mot 2007, 93:63–71.
27. Papadopoulos O, Frantzoglou M, Chrisostomidis C, Konofaos P, Frangoulis
M, Barlas G: Neglected squamous cell carcinoma of the frontal area:
a clinical report. J Craniofac Surg 2006, 17:1015–1020.
28. Copcu E: Marjolin’s ulcer a preventable complication of bums.
Plast Reconstr Surg 2009, 124:156e–164e.
29. Emsen IM: A great Marjolin’s ulcer of the scalp invading outer calvarial
bone and its different treatment with support of medpor. J Craniofac
Surg 2008, 19:1026–1029.30. Ko Y, Han YM, Hwang HS, Lee ES, Lee GK: Role of 18 F-FDG PET/CT in the
diagnosis of clinically suspected Marjolin ulcer. AJR Am J Roentgenol 2012,
199(6):1375–1379.
31. Hansen SL, Mathes SJ: Problem wounds and principles of closure.
In Plastic Surgery. Edited by Mathes SJ. Philadelphia: Saunders Elsevier;
2006:916.
32. Tiftikcioglu YO, Ozek C, Bilkay U, Uckan A, Akin Y: Marjolin ulcers arising on
extremities. Ann Plast Surg 2010, 64(3):318–320.
doi:10.1186/1477-7819-11-313
Cite this article as: Yu et al.: Marjolin’s ulcer: a preventable malignancy
arising from scars. World Journal of Surgical Oncology 2013 11:313.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
